JG
AVTX icon

Jain Global’s Avalo Therapeutics AVTX Stock Holding History

Jain Global’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+12,686
New +$201K ﹤0.01% 1484
2026
Q1 		– Sell
-217,292
Closed -$3.95M – 1218
2025
Q4 		$3.95M Buy
+217,292
New +$3.67M 0.02% 464

Other funds holding AVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jain Global's AVTX Position: Q2 2026 in Review

Jain Global opened a new position in Avalo Therapeutics (AVTX) in Q2 2026: 12,686 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #1484 among its holdings. This is a return to the name: Jain Global previously reported a position in AVTX as recently as Q4 2025.

Jain Global first reported a position in AVTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.95M in Q4 2025. 126 funds tracked by Wall St. Rank hold AVTX as of Q2 2026.

  • Jain Global held 12,686 shares of Avalo Therapeutics worth $234K as of Q2 2026.
  • Avalo Therapeutics was a new Jain Global position in Q2 2026.
  • Avalo Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1484 holding.
  • Jain Global first reported a position in Avalo Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's Avalo Therapeutics position peaked at $3.95M in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.